Leukemia Research Reports Oncology
CD19-negative relapse with an apparent cytogenetic shift after blinatumomab-induced measurable residual disease clearance in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia
The publisher did not provide an abstract — full text is available via the link below.